Trial Profile
A Randomized, Controlled Phase 3 Study to Evaluate Safety and Efficacy of Fibrin Sealant (FS) VH S/D 4 S-apr (ARTISS) to Adhere Tissues and Improve Wound Healing in Subjects Undergoing Rhytidectomy (Facelift)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Nov 2014
Price :
$35
*
At a glance
- Drugs Fibrinogen/thrombin (Primary)
- Indications Wounds
- Focus Adverse reactions; Therapeutic Use
- Sponsors Baxter Healthcare Corporation
- 20 Nov 2014 New trial record